CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2014—Trinity Biotech’s Meritas Troponin I (TnI) point-of-care test obtained CE marking. The test enables accurate triage and intervention for emergency department patients with possible myocardial infarction; results are available in 15 minutes. With CE marking achieved, the company intends to sell the product in Europe and other carefully selected markets.
Trinity Biotech, +353-1-276 9800